A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer

Journal of Chemotherapy

Volumn 14, Issue 2, 2002, Pages 207-213

  Basaran, Mert ^a   Bavbek, S E ^a   Gullu I ^a   Demirelli, F ^a   Sakar, B ^a   Tenekeci, N ^a   Altun, M ^a   Yalcin S ^a   Onat, H ^a  

^a NONE   (Turkey)

Author keywords

Chemotherapy; Cisplatin; Head and neck cancer; Paclitaxel

Indexed keywords

CISPLATIN; DEXAMETHASONE; PACLITAXEL; PHENIRAMINE; RANITIDINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; KIDNEY DISEASE; MALE; METASTASIS; MUCOSA INFLAMMATION; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VOMITING;

EID: 0036242216     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.2.207     Document Type: Article

References (22)

1. A phase III randomized study comparing cisplatin and 5-fluorouracil as single agents and in combination for advanced squamous cell carsinoma of the head and neck
2. Randomized comparison of cisplatin, methotrexate, bleomycin, and vincristine (VABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin in recurrent or metastatic squamous cell carcinoma of head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group
3. Randomized comparison of cisplatin plus 5-fluorouracil and carboplatin plus 5-fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck. A Southwest Oncology Group study
4. Docetaxel (taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck
5. Docetaxel: An active drug for squamous cell carcinoma of the head and neck
6. Paclitaxel (Taxol) for the treatment of the head and neck cancer
7. Scheduled and dose intensified paclitaxel as weekly one-hour infusion in pretreated solid tumors: Results of phase I/II trial
8. A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck
9. Sequences of Taxol and cisplatin: A phase I and pharmacokinetics study
10. Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer
11. Chemotherapy for recurrent and metastatic head and neck cancer
12. Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group
13. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck: A Northern California Oncology Group study
14. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer
15. Chemotherapy for head and neck cancer: Comparison of cisplatin + vinblastine + bleomycin versus methotrexate
16. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer
17. Single agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer
18. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma
19. Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck
20. Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393
21. Phase I-II study of paclitaxel/cisplatin as a first line therapy for locally advanced head and neck cancer
22. Phase III study comparing cisplatin & fluorouracil versus cisplatin & paclitaxel in metastatic/recurrent head and neck cancer